Reunion Neuroscience Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a REUN research report →
About the company
Field Trip Health Ltd. is a North American company specializing in the development and delivery of psychedelic-assisted therapies. The organization operates Field Trip Health Centres, which offer psychedelic-based treatments, and provides digital applications under the Field Trip brand.
- CEO
- Gregory T. Mayes
- IPO
- 2020
- Employees
- 16
- HQ
- Toronto, ON, CA
Price Chart
- Market Cap
- $13.12M
- P/E
- -0.34
- P/S
- 0.00
- P/B
- 0.78
- EV/EBITDA
- 0.42
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -109.89%
- ROIC
- -82.61%
- Revenue
- $0 · -100.00%
- Net Income
- $-66,220,667 · -18.70%
- EPS
- $-5.69 · -17.81%
- Op Income
- $-20,374,630
- FCF YoY
- 41.19%
- 52W High
- $21.56
- 52W Low
- $0.63
- 50D MA
- $1.02
- 200D MA
- $1.12
- Beta
- 4.20
- Avg Volume
- 429.86K
Get TickerSpark's AI analysis on REUN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our REUN coverage
Recent articles, reports, and earnings notes.
No research on REUN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate REUN report →Similar companies
Peers in the same neighborhood.